Shockwave Medical Inc., a subsidiary of Johnson & Johnson, is dedicated to advancing healthcare through innovative medical technologies. The company focuses on developing less invasive treatment options for complex diseases, particularly in the field of interventional cardiology. With a commitment to improving patient outcomes, Shockwave Medical is involved in clinical trials and the development of novel therapies, aiming to transition groundbreaking treatments from clinical settings to commercial availability. The organization values collaboration, education, and building long-term relationships with healthcare professionals to enhance therapy awareness and patient enrollment in clinical studies.